株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

タンパク質工学 (プロテインエンジニアリング) の世界市場予測 2020年:モノクロナール抗体・インターフェロン・成長ホルモン

Protein Engineering Market: Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) Global Forecast to 2020

発行 MarketsandMarkets 商品コード 265103
出版日 ページ情報 英文 156 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
タンパク質工学 (プロテインエンジニアリング) の世界市場予測 2020年:モノクロナール抗体・インターフェロン・成長ホルモン Protein Engineering Market: Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) Global Forecast to 2020
出版日: 2015年03月24日 ページ情報: 英文 156 Pages
概要

タンパク質工学市場は今後15.7%のCAGRで拡大し、2020年までに14億6,300万米ドルに達すると予測されています。

当レポートでは、タンパク質工学の世界市場について、技術、製品、タンパク質種類、エンドユーザーおよび地域別に分析しており、市場成長の促進因子と阻害因子の分析、主要企業のプロファイルなどをまとめ、概略下記の構成で取り上げております。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • タンパク質工学市場における魅力的な市場機会
  • 市場:エンドユーザー別
  • 市場:技術別
  • 市場:製品別
  • 市場成長機会:地域別
  • ライフサイクル分析:地域別

第5章 市場概要

  • イントロダクション
  • 市場力学

第6章 産業考察

  • イントロダクション
  • サプライチェーン分析
  • ポーターのファイブフォース分析
  • 戦略的ベンチマーキング

第7章 タンパク質工学の世界市場:製品別

  • イントロダクション
  • 器具
  • 試薬
  • サービス & ソフトウェア

第8章 タンパク質工学の世界市場:技術別

  • イントロダクション
  • 有理式タンパク質設計
  • 無理式タンパク質設計

第9章 タンパク質工学の世界市場:タンパク質種類別

  • イントロダクション
  • モノクロナール抗体
  • インスリン
  • エリスロポエチン
  • インターフェロン
  • コロニー刺激因子
  • 成長ホルモン
  • 凝固因子
  • ワクチン
  • その他

第10章 タンパク質工学の世界市場:エンドユーザー別

  • イントロダクション
  • 学術研究機関
  • 製薬 & バイオテクノロジー企業
  • 開発業務受託機関

第11章 地域分析

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第12章 競合情勢

  • 概要
  • 市場シェアを巡る戦い:主要戦略だった新製品発売
  • 新製品発売
  • 合意、提携、および協力
  • 拡大
  • 買収

第13章 企業プロファイル

  • Agilent Technologies, Inc
  • Bio-Rad Laboratories, Inc
  • Bruker Corporation
  • Danaher Corporation
  • General Electric
  • Perkinelmer, Inc
  • Genscripts Usa, Inc.
  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific
  • Waters Corporation

第14章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 3258

Developing Asian countries such as the China and India are lucrative markets for protein engineering, owing to increase in R&D investment by the biologics companies in these regions.

The report segments the global protein engineering market product, technology, protein type, end user, and region. Instruments accounted for the largest share of the global Protein engineering market, by product in 2014. However, services and software is expected to grow at the highest CAGR during the forecast period, owing to ongoing technological advancements in this segment.

Rational protein design accounted the largest share of protein engineering market, by technology in 2014. This large share is attributed to increase in adoption of this technique over irrational protein design.

Based on protein type, the market is categorized into monoclonal antibodies, insulin, erythropoietin, interferon, colony stimulating factor, growth hormones, coagulation factor, vaccines and others (interleukins, follicle stimulating hormones, enzyme replacement). Monoclonal antibodies is the largest as well as fastest growing segment of the protein engineering protein type market. This growth is attributed to the increase in adoption of them for various therapies such as cancer and autoimmune diseases.

On the basis of end user, the protein engineering market is categorized academic research institutes, pharmaceutical and biotechnology companies, and contract research organizations. Pharmaceutical and biotechnology companies is the largest and fastest-growing end user segment. The high growth rate of this segment can be attributed to technological advancements in protein engineering and the increase in R&D budgets in the pharmaceutical sector.

New and innovative product launches was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs.

From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the protein engineering market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Table of Contents

1 Introduction

  • 1.1 Objectives of the Study
  • 1.2 Market Definition
  • 1.3 Markets Covered
  • 1.4 Years Considered for the Study
  • 1.5 Currency
  • 1.6 Limitations
  • 1.7 Stakeholders

2 Research Methodology

  • 2.1 Market Size Estimation
  • 2.2 Market Crackdown and Data Triangulation
    • 2.2.1 Key Data From Secondary Sources
    • 2.2.2 Key Data From Primary Sources
      • 2.2.2.1 Key Industry Insights
    • 2.2.3 Assumptions

3 Executive Summary

4 Premium Insights

  • 4.1 Attractive Opportunities in the Protein Engineering Market
  • 4.2 Market, By End User
  • 4.3 Market, By Technology
  • 4.4 Market, By Product
  • 4.5 Market Growth Opportunities, By Region
  • 4.6 Lifecycle Analysis, By Region

5 Market Overview

  • 5.1 Introduction
  • 5.2 Market Dynamics
    • 5.2.1 Drivers
      • 5.2.1.1 Increase in Adoption of Protein-Based Drugs Over Non-Protein-Based Drugs
      • 5.2.1.2 Reduction in Overall Timeline and Cost for Drug Discovery
      • 5.2.1.3 High Prevalence Rate of Lifestyle Diseases
      • 1.2.1.4 Growth in Funding for Protein Engineering
    • 5.2.2 Restraints
      • 5.2.2.1 Expensive and High Maintenance Tools and Instruments Used in Protein Engineering
    • 5.2.3 Opportunities
      • 5.2.3.1 Significant Growth Prospects in Developing Countries
      • 5.2.3.2 Protein Therapy as an Alternative to Gene Therapy
      • 5.2.3.3 Top-Selling Biologics Drugs Going Off-Patent in the Near Future
    • 5.2.4 Challenges
      • 5.2.4.1 Need for Qualified Researchers and Mandatory Training in Protein Engineering Increases Cost of Process
    • 5.2.5 Winning Imperatives
      • 5.2.5.1 Site-Directed Mutagenesis is A Breakthrough Technology Augmenting the Growth of the Protein Engineering Market

6 Industry Insights

  • 6.1 Introduction
  • 6.2 Supply Chain Analysis
    • 6.2.1 Key Influencers
  • 6.3 Porter's Five Forces Analysis
    • 6.3.1 Threat From New Entrants
    • 6.3.2 Threat From Substitutes
    • 6.3.3 Bargaining Power of Buyers
    • 6.3.4 Bargaining Power of Suppliers
    • 6.3.5 Intensity of Rivalry
  • 6.5 Strategic Benchmarking
    • 6.5.1 New Product Launches

7 Protein Engineering Market, By Product

  • 7.1 Introduction
  • 7.2 Instruments
  • 7.3 Reagents
  • 7.4 Services & Software

8 Protein Engineering Market, By Technology

  • 8.1 Introduction
  • 8.2 Rational Protein Design
  • 8.2 Irrational Protein Design

9 Protein Engineering Market, By Protein Type

  • 9.1 Introduction
  • 9.2 Monoclonal Antibodies
  • 9.3 Insulin
  • 9.4 Erythropoietin
  • 9.5 Interferon
  • 9.6 Colony Stimulating Factor
  • 9.7 Growth Hormones
  • 9.8 Coagulation Factor
  • 9.9 Vaccines
  • 9.10 Others

10 Protein Engineering Market, By End User

  • 10.1 Introduction
  • 10.2 Academic Research Institutes
  • 10.3 Pharmaceutical & Biotechnology Companies
  • 10.4 Contract Research Organizations

11 Geographic Analysis

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 India
    • 11.4.3 Japan
    • 11.4.4 Rest of Asia (ROA)
  • 11.5 Rest of the World (ROW)

12 Competitive Landscape

  • 11.1 Overview
  • 11.2 Battle for Market Share: New Product Launches Was the Key Strategy
  • 11.3 New Product Launches
  • 11.4 Agreements, Partnerships, and Collaborations
  • 11.5 Expansions
  • 11.6 Acquisitions

12 Company Profile

  • 12.1 Agilent Technologies, Inc
    • 12.1.1 Business Overview
    • 12.1.2 Product Portfolio
    • 12.1.3 Key Strategy
    • 12.1.4 Recent Developments
  • 12.2 Bio-Rad Laboratories, Inc
    • 12.2.1 Business Overview
    • 12.2.2 Product Portfolio
    • 12.2.3 Key Strategy
    • 12.2.4 Recent Developments
  • 12.3 Bruker Corporation
    • 12.3.1 Business Overview
    • 12.3.2 Product Portfolio
    • 12.3.3 Key Strategy
    • 12.3.4 Recent Developments
    • 12.3.5 SWOT Analysis
    • 12.3.6 MNM View
  • 12.4 Danaher Corporation
    • 12.4.1 Business Overview
    • 12.4.2 Products & Services
    • 12.4.3 Key Strategy
    • 12.4.4 Recent Developments
  • 12.5 General Electric
    • 12.5.1 Business Overview
    • 12.5.2 Product Portfolio
    • 12.5.3 Key Strategy
    • 12.5.4 Recent Developments
  • 12.6 Perkinelmer, Inc
    • 12.6.1 Products & Services
    • 12.6.2 Key Strategy
    • 12.6.3 Recent Developments
  • 12.7 Genscripts Usa, Inc.
    • 12.7.1 Business Overview
    • 12.7.2 Key Strategy
    • 12.7.3 Recent Developments
  • 12.8 Sigma-Aldrich Corporation
    • 12.8.1 Business Overview
    • 12.8.2 Product Portfolio
    • 12.8.3 Key Strategy
    • 12.8.4 Recent Developments
  • 12.9 Thermo Fisher Scientific
    • 12.9.1 Business Overview
    • 12.9.2 Product Portfolio
    • 12.9.3 Key Strategy
    • 12.9.4 Recent Developments
  • 12.10 Waters Corporation
    • 12.10.1 Business Overview
    • 12.10.2 Product Portfolio
    • 12.10.3 Key Strategy
    • 12.10.4 Recent Developments

13 Appendix

  • 13.1 Insights of Industry Experts
  • 13.2 Discussion Guide
  • 13.3 Introducing RT: Real-Time Market Intelligence
  • 13.4 Available Customizations
  • 13.5 Related Reports

List of Tables

  • Table 1 Protein Engineering Market Size, By Technology, 2013-2020 ($Million)
  • Table 2 Rational Protein Design Market Size, By Region, 2013-2020 ($Million)
  • Table 3 North America: Rational Protein Design Market Size, By Country, 2013-2020 ($Million)
  • Table 4 Asia: Rational Protein Design Market Size, By Country, 2013-2020 ($Million)
  • Table 5 Irrational Protein Design Market Size, By Region, 2013-2020 ($Million)
  • Table 6 North America: Irrational Protein Design Market Size, By Country, 2013-2020 ($Million)
  • Table 7 Asia: Irrational Protein Design Market Size, By Country, 2013-2020 ($Million)
  • Table 8 Market Size, By Product, 2013-2020 ($Million)
  • Table 9 Market Size for Instruments, By Region, 2013-2020 ($Million)
  • Table 10 North America: Market Size for Instruments, By Country, 2013-2020 ($Million)
  • Table 11 Asia: Market Size for Instruments, By Country/Region, 2013-2020 ($Million)
  • Table 12 Market Size for Reagents, By Region, 2013-2020 ($Million)
  • Table 13 North America: Market Size for Reagents, By Country, 2013-2020 ($Million)
  • Table 14 Asia: Market Size for Reagents, By Country/Region, 2013-2020 ($Million)
  • Table 15 Market Size for Services and Software, By Region, 2013-2020 ($Million)
  • Table 16 North America: Market Size for Services and Software, By Country, 2013-2020 ($Million)
  • Table 17 Asia: Market Size for Services and Software, By Country/Region, 2013-2020 ($Million)
  • Table 18 Market Size, By Protein Type, 2013-2020 ($Million)
  • Table 19 Monoclonal Antibodies Market Size, By Region, 2013-2020 ($Million)
  • Table 20 North America: Monoclonal Antibodies Market Size, By Country, 2013-2020 ($Million)
  • Table 21 Asia: Monoclonal Antibodies Market Size, By Country, 2013-2020 ($Million)
  • Table 22 Insulin Market Size, By Region, 2013-2020 ($Million)
  • Table 23 North America: Insulin Market Size, By Country, 2013-2020 ($Million)
  • Table 24 Asia: Insulin Market Size, By Country, 2013-2020 ($Million)
  • Table 26 Erythropoietin Market Size, By Region, 2013-2020 ($Million)
  • Table 27 Asia: Erythropoietin Market Size, By Country, 2013-2020 ($Million)
  • Table 28 Interferons Market Size, By Region, 2013-2020 ($Million)
  • Table 29 North America: Interferons Market Size, By Country, 2013-2020 ($Million)
  • Table 30 Asia: Interferons Market Size, By Country, 2013-2020 ($Million)
  • Table 31 Colony Stimulating Factors Market Size, By Region, 2013-2020 ($Million)
  • Table 32 North America: Colony Stimulating Factors Market Size, By Country, 2013-2020 ($Million)
  • Table 33 Asia: Colony Stimulating Factor Market Size, By Country, 2013-2020 ($Million)
  • Table 34 Growth Hormones Market Size, By Region, 2013-2020 ($Million)
  • Table 35 North America: Growth Hormones Market Size, By Country, 2013-2020 ($Million)
  • Table 36 Asia: Growth Hormones Market Size, By Country, 2013-2020 ($Million)
  • Table 37 Coagulation Factors Market Size, By Region, 2013-2020 ($Million)
  • Table 38 North America: Coagulation Factors Market Size, By Country, 2013-2020 ($Million)
  • Table 39 Asia: Coagulation Factors Market Size, By Country, 2013-2020 ($Million)
  • Table 40 Vaccines Market Size, By Region, 2013-2020 ($Million)
  • Table 41 North America: Vaccines Market Size, By Country, 2013-2020 ($Million)
  • Table 42 Asia: Vaccines Market Size, By Country, 2013-2020 ($Million)
  • Table 43 Other Proteins Market Size, By Region, 2013-2020 ($Million)
  • Table 44 North America: Other Proteins Market Size, By Country, 2013-2020 ($Million)
  • Table 45 Asia: Other Proteins Market Size, By Country, 2013-2020 ($Million)
  • Table 46 Global Market Size, By End User, 2013-2020 ($Million)
  • Table 47 Market Size for Academic Research Institutes, By Region, 2013-2020 ($Million)
  • Table 48 North America: Market Size for Academic Research Institutes, By Country, 2013-2020 ($Million)
  • Table 49 Asia: Market Size for Academic Research Institutes, By Country/Region, 2013-2020 ($Million)
  • Table 50 Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2013-2020 ($Million)
  • Table 51 North America: Market Size for Pharmaceutical and Biotechnology Companies, By Country, 2013-2020 ($Million)
  • Table 52 Asian Market Size for Pharmaceutical and Biotechnology Companies, By Country/Region, 2013-2020 ($Million)
  • Table 53 Market Size for CROS, By Region, 2013-2020 ($Million)
  • Table 54 North America: Market Size for CROS, By Country, 2013-2020 ($Million)
  • Table 55 Asia: Market Size for Pharmaceutical and Biotechnology Companies, By Country/Region, 2013-2020 ($Million))
  • Table 56 Protein Engineering Market Size, By Region, 2013-2020 ($Million))
  • Table 57 North America: Market Size, By Country, 2013-2020 ($Million)
  • Table 58 North America: Market Size, By Product, 2013-2020 ($Million)
  • Table 59 North America: Market Size, By Technology, 2013-2020 ($Million))
  • Table 60 North America: Market Size, By Protein Type, 2013-2020 ($Million)
  • Table 61 North America: Market Size, By End User, 2013-2020
  • Table 62 U.S.: Market Size, By Product, 2013-2020 ($Million)
  • Table 63 U.S.: Market Size, By Technology, 2013-2020 ($Million)
  • Table 64 U.S.: Market Size, By Protein Type, 2013-2020 ($Million)
  • Table 65 U.S.: Market Size, By End User, 2013-2020 ($Million)
  • Table 66 Canada: Market Size, By Product, 2013-2020 ($Million)
  • Table 67 Canada: Market Size, By Technology, 2013-2020 ($Million)
  • Table 68 Canada: Market Size, By Protein Type, 2013-2020 ($Million)
  • Table 69 Canada: Market Size, By End User, 2013-2020 ($Million)
  • Table 70 Europe: Market Size, By Product, 2013-2020 ($Million)
  • Table 71 Europe: Market Size, By Technology, 2013-2020 ($Million)
  • Table 72 Europe: Market Size, By Protein Type, 2013-2020 ($Million)
  • Table 73 Europe: Market Size, By End User, 2013-2020 ($Million)
  • Table 74 Asia: Protein Engineering Market Size, By Country, 2013-2020 ($Million))
  • Table 75 Asia: Protein Engineering Market Size, By Product, 2013-2020 ($Million)
  • Table 76 Asia: Market Size, By Technology, 2013-2020 ($Million)
  • Table 77 Asia: Market Size, By Protein Type, 2013-2020 ($Million)
  • Table 78 Asia: Protein Engineering Market Size, By End User, 2013-2020
  • Table 79 China: Protein Engineering Market Size, By Product, 2013-2020 ($Million)
  • Table 80 China: Market Size, By Technology, 2013-2020 ($Million)
  • Table 81 China: Market Size, By Protein Type, 2013-2020 ($Million)
  • Table 82 China: Protein Engineering Market Size, By End User, 2013-2020 ($Million)
  • Table 83 India: Market Size, By Product, 2013-2020 ($Million)
  • Table 84 India: Market Size, By Technology, 2013-2020 ($Million)
  • Table 85 India: Market Size, By Protein Type, 2013-2020 ($Million)
  • Table 86 Japan: Protein Engineering Market Size, By Product, 2013-2020 ($Million)
  • Table 87 Japan: Protein Engineering Market Size, By Technology, 2013-2020 ($Million)
  • Table 88 Japan: Protein Engineering Market Size, By Protein Type, 2013-2020 ($Million)
  • Table 89 Japan: Protein Engineering Market Size, By End User, 2013-2020 ($Million)
  • Table 90 ROA: Protein Engineering Market Size, By Product, 2013-2020 ($Million)
  • Table 91 ROA: Market Size, By Technology, 2013-2020 ($Million)
  • Table 92 ROA: Market Size, By Protein Type, 2013-2020 ($Million)
  • Table 93 ROW: Protein Engineering Market Size, By Product, 2013-2020 ($Million)
  • Table 94 ROW: Protein Engineering Market Size, By Technology, 2013-2020 ($Million)
  • Table 95 ROW: Protein Engineering Market Size, By Protein Type, 2013-2020 ($Million
  • Table 96 ROW: Market Size, By End User, 2013-2020 ($Million)
  • Table 97 New Product Launches, 2012-2015
  • Table 98 Agreements, Partnerships, and Collaborations, 2011-2015
  • Table 99 Expansions 2012-2015
  • Table 100 Acquisitions, 2012-2015

List of Figures

  • Figure 1 Research Methodology
  • Figure 2 Market Size Estimation
  • Figure 3 Break Down of Primary Interviews: By Company Type, Designation, and Region
  • Figure 4 Market Data Triangulation Methodology
  • Figure 5 Protein Engineering Market Snapshot (2014 vs. 2020
  • Figure 6 Pharmaceutical and Biotechnology Companies Will Continue to Dominate the Protein Engineering Market During the Forecast Period
  • Figure 7 Protein Engineering Technology Market Snapshot (2014 vs. 2019): Rational Design to Witness Highest Growth Rate in the Next Five Years
  • Figure 8 Asia Expected to Be the Fastest-Growing Market During the Forecast Period
  • Figure 9 New Product Launches Was the Major Strategy Adopted By Industry Players
  • Figure 10 Market Growth Will Be Driven By Increasing Adoption of Biologics
  • Figure 11 Pharmaceutical and Biotechnology Companies Accounted for the Largest Share in 2014
  • Figure 12 Rational Protein Design is Expected to Dominate the Technology Market During the Forecast Period
  • Figure 13 Software and Services Segment Holds Lucrative Growth Opportunities
  • Figure 14 Asia to Witness the Highest Grow Rate From 2015 to 2020
  • Figure 15 Asia Holds Lucrative Growth Opportunities
  • Figure 16 Protein Engineering Market: Technological Evolution
  • Figure 17 Protein Engineering Market: Drivers, Restraints, Opportunities, and Challenges
  • Figure 18 Direct Distribution-Strategy Preferred By Prominent Companies
  • Figure 19 Requirement of High Capital Investment to Restrict Entry of New Players
  • Figure 20 Market Leaders Adopted the Organic Growth Strategy of New Product Launches
  • Figure 21 Instruments Expected to Be the Largest Segment in Forecast Period
  • Figure 22 North America Will Continue to Lead Protein Engineering Instruments Market for the Forecast Period
  • Figure 23 Asian Reagents Segment to Show Fastest Growth
  • Figure 24 Snapshot: Rational and Irrational Protein Design
  • Figure 25 Rational Protein Design Segment Will Continue to Dominate the Market in the Forecast Period
  • Figure 26 North America Accounted for the Largest Share in the Rational Protein Design Market
  • Figure 27 Monoclonal Antibodies Will Continue to Dominate the Market in the Forecast Period
  • Figure 28 North America Accounted for the Largest Share in the Insulin Market
  • Figure 30 North America Commanded the Largest Share of the Erythropoietin Market in 2014
  • Figure 31 Asia is the Fastest Growing Segment of the CSF Market
  • Figure 32 Asia is the Fastest Growing Market for the Forecast Period
  • Figure 33 North America Commanded the Largest Share of Others Market in 2014
  • Figure 34 Broad End-User Base of Protein Engineering
  • Figure 35 North America Dominates the Protein Engineering Market for Academic Research Institutes
  • Figure 36 Asia Will Be the Fastest-Growing Market By 2020
  • Figure 37 Asia An Attractive Destination for Protein Engineering
  • Figure 38 Government Funding and Technology Advancements To drive Demand for Protein Engineering
  • Figure 39 Rational Design Segment Will Continue to Lead the Protein Engineering Technologies Market in the U.S.
  • Figure 40 Rational Protein Design Technology Segment Expected to Grow at the Highest Rate From 2015 to 2020
  • Figure 41 European Protein Engineering Market Snapshot
  • Figure 42 Japan Will Continue to Dominate the Asian Protein Engineering Market in the Next Five Years
  • Figure 43 Instruments Segment to Witness the Highest Growth in the ROW Region
  • Figure 44 Geographic Revenue Mix of Top 4 Market Players
  • Figure 45 Agilent Technologies, Inc.: Company Snapshot
  • Figure 46 Bio-Rad Laboratories, Inc.: Company Snapshot
  • Figure 47 Bruker Corporation: Company Snapshot
  • Figure 48 Danahar Corporation: Company Snapshot
  • Figure 49 General Electric: Company Snapshot
  • Figure 50 Genscript Usa, Inc.: Company Snapshot
  • Figure 51 Perkinelmer, Inc.: Company Snapshot
  • Figure 52 Sigma-Aldrich Corporation: Company Snapshot
  • Figure 53 Thermo Fisher Scientific, Inc.: Company Snapshot
Back to Top